Rocket Pharmaceuticals Inc. (RCKT) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Rocket Pharmaceuticals In...

    NASDAQ: RCKT · Real-Time Price · USD
    3.15
    -0.06 (-1.87%)
    At close: Oct 03, 2025, 3:59 PM
    3.16
    0.32%
    Pre-market: Oct 06, 2025, 06:31 AM EDT

    Rocket Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -4.61 -10.25 -6.08 -8.14
    PEG Ratio
    		 0.71 0.98 -0.28 -1.28
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 2.57 5.11 2.72 3.04
    P/FCF Ratio
    		 -5.53 -11.91 -7.14 -10.71
    P/OCF Ratio
    		 -5.68 -12.92 -7.49 -11.39
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.06 0.05 0.05 0.05
    Quick Ratio
    		 9.30 7.80 9.29 17.69
    Current Ratio
    		 9.30 7.80 9.29 17.69
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -144.86 -138.48 -117.52 -28.4
    Return on Equity
    		 -0.56 -0.5 -0.45 -0.37
    Return on Assets
    		 -0.49 -0.43 -0.4 -0.34
    Return on Invested Capital
    		 -0.56 -0.5 -0.43 -0.35
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist